Expansion of HER2/neu-Specific T Cells Ex Vivo Following Immunization with a HER2/neu Peptide-Based Vaccine
- 1 April 2001
- journal article
- review article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 2 (1) , 73-79
- https://doi.org/10.3816/cbc.2001.n.014
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patientsJournal of Clinical Investigation, 2001
- Effects of Interleukin-15 onIn VitroHuman T Cell Proliferation and ActivationJournal of Interferon & Cytokine Research, 2000
- T‐cell survivalImmunological Reviews, 1998
- Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10.The Journal of Experimental Medicine, 1996
- Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytesNature Medicine, 1996
- Induction of anti-self-immunity to cure cancerCell, 1995
- Interleukin-7—Dependent Interaction of Dendritic Epidermal T Cells with KeratinocytesJournal of Investigative Dermatology, 1995
- Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines.The Journal of Experimental Medicine, 1995
- Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.The Journal of Experimental Medicine, 1988
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987